Larvol Delta - Coblopasvir-and-sofosbuvir-for-treatment-of-chronic-hepatitis-C-virus-infection-in-China-A-singlearm-openlabel-phase-3-trial

coblopasvir (KW 136) - Beijing Kawin

Sovaldi (sofosbuvir) - Gilead

http://www.ncbi.nlm.nih.gov/pubmed/33047868

Oct 15, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next